0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Effect of Gonadal Hormones on Luteinizing Hormone in Plasma and on Choline Acetyltransferase Activity and Acetylcholine Levels in Discrete Nuclei of the Rat Brain

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In order to assess the possible involvement of central cholinergic mechanisms in the feedback actions of gonadal hormones, the activity of choline acetyltransferase (ChAT) and the concentration of acetylcholine (ACh) were measured in microdissected brain nuclei of male and female rats after castration and gonadal hormone replacement. Castration of male rats significantly elevated plasma levels of LH and also increased ChAT activity and ACh level in the medial preoptic nucleus. Castration also increased ChAT activity but not ACh concentration in the posteromedial amygdala. In the rostral part of the nucleus tractus diagonalis and in the ventral tegmental area. ACh concentrations were elevated by castration, but ChAT activity was unaffected. Daily administration of testosterone propionate (TP) to castrated males attenuated the postcastration rise of plasma LH and also partially prevented the increases of ACh in the medial preoptic and rostral tractus diagonalis nuclei and of ChAT in the posteromedial amygdala. In addition, TP treatment significantly decreased ChAT acivity in the rostral nucleus tractus diagonalis. Treatment of ovariectomized female rats with estradiol benzoate lowered plasma levels of LH, but did not affect cholinergic parameters. Administration of progesterone to estrogen-primed females produced a surge in plasma LH and decreased the activity of ChAT and the concentration of ACh in the periventricular nucleus. Such treatment also reduced ChAT activity in the caudal nucleus tractus diagonalis and decreased ACh levels in the ventral tegmental area. The combined estradiol/progesterone treatment elevated ChAT activity in the supraoptic nucleus. These results demonstrate that cholinergic activity in several discrete brain regions known to be targets for testicular and ovarian hormones is altered by gonadectomy and gonadal hormone treatment and suggest involvement of cholinergic systems in the feedback effects of estadiol, progesterone and testosterone.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1980
          1980
          26 March 2008
          : 30
          : 6
          : 329-336
          Affiliations
          Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Md., and Department of Pharmacology, George Washington University Medical Center, Washington, D.C.
          Article
          123024 Neuroendocrinology 1980;30:329–336
          10.1159/000123024
          7383272
          © 1980 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 8
          Categories
          Original Paper

          Comments

          Comment on this article